Recieved this email yesterday from Tandem. Partial excerpt:
We just announced U.S. Food and Drug Administration (FDA) clearance of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology. Control-IQ technology is designed to help prevent highs and lows by using Dexcom G6 continuous glucose monitor (CGM) values to predict sensor glucose levels 30 minutes ahead.* The t:slim X2 insulin pump then adjusts basal insulin accordingly, including delivery of automatic correction boluses as needed, to help increase time in range (70–180 mg/dL).†,‡
*Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 continuous glucose monitoring (CGM) integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. CGM sold separately.
As an in-warranty t:slim X2 insulin pump user, you will soon have the option to update your pump software to Control-IQ technology at your convenience, and at no additional cost.§
No action is required at this time
You will receive an email as soon as the software update becomes available. We expect to begin rolling out software updates in January 2020.
The process will be managed through an easy-to-use online portal. In the upcoming weeks, you will receive an email with instructions on how to get the process started. The process will consist of three steps: